These U.S. Colleges and Majors Are the Biggest Waste of Money - Derek Thompson - The Atlantic

By Editorial Team -
These U.S. Colleges and Majors Are the Biggest Waste of Money - Derek Thompson - The Atlantic

Comments

Post a Comment

Pages

Popular posts from this blog

AI Crypto Trading Competition 2025: DeepSeek and Qwen3 Dominate as Gemini and GPT-5 Suffer Major Losses

By -
Image
In this Article: AI models like DeepSeek, and Qwen3 are up big in a live, real-money crypto trading showdown. GPT 5 is the biggest loser of the bunch, underscoring reliability and transparency risks. The results deepen the divide between data-specialized and general-purpose AI approaches to finance. In early innings, DeepSeek , and Qwen3 are emerging as the top performers in a real-money AI crypto trading showdown, each generating returns of over 30% so far while rival models have suffered heavy losses. The " Alpha Arena ," a competition that pits prominent large language models against each other in the live cryptocurrency market, saw OpenAI's GPT-5  with staggering losses of more than 70% during the same period. ( decrypt.co ) In Alpha Arena, launched by US research firm Nof1, six large language models (LLMs) were given US$10,000 each to invest in six cryptocurrency perpetual contracts on the decentralised exchange Hyperliquid, including bitcoin and solana. The other LL...
Read more

Top 10 Pharmaceutical Companies by Revenue and Market Cap in 2025 (October Edition)

By -
Image
The pharmaceutical industry continues to show robust performance in Q3 2025, with key players reporting strong sales driven by oncology, immunology, and metabolic drugs. Eli Lilly maintains its lead in market capitalization, fueled by high demand for its GLP-1 treatments Mounjaro and Zepbound, with projected full-year revenue growth of around 32%. Johnson & Johnson reported Q3 sales of $24.0 billion, up 6.8%, and raised its 2025 sales outlook. Roche achieved 7% sales growth in the first nine months to CHF 45.9 billion ($52.8 billion), raising its full-year guidance to mid-single-digit growth. Other top companies like AstraZeneca, Novartis, and Vertex reported double-digit growth in key segments. Challenges persist, including patent expirations and biosimilar competition, but new approvals and acquisitions signal continued innovation. This edition updates data with Q3 2025 figures where available. Credit:  fiercepharma.co...
Read more

Top 10 Stocks and ETFs Poised to Outperform in October 2025

By -
Image
In light of the recent stock market tumble on October 10, 2025, triggered by renewed threats of massive tariffs on Chinese imports announced by President Trump, investors are facing heightened uncertainty. This event has exacerbated ongoing volatility that began earlier in the year with the broader 2025 stock market crash, which started on April 2 amid new tariff policies.  Related: AI Market Predictions for 2025: Hits, Misses, and Ongoing Trends as of October 2025 With the Federal Reserve maintaining its rate-cutting trajectory into October 2025 amid heightened market volatility and sector rotation, opportunities are emerging in small caps, semiconductors/AI, value stocks, and gold miners as hedges. Based on recent analyses from Zacks, Morningstar, Yahoo Finance, and ETF experts, we've compiled a forward-looking list of 20 recommendations (10 stocks and 10 ETFs) expected to capitalize on these trends through the end of October and into Q4. Selections e...
Read more

Top 10 Stock Picks for October 2025: Best Funds to Buy Now for Growth, Safety, and Diversification Amid Recent Market Volatility

By -
Image
In light of the recent stock market tumble on October 10, 2025, triggered by renewed threats of massive tariffs on Chinese imports announced by President Trump, investors are facing heightened uncertainty. This event has exacerbated ongoing volatility that began earlier in the year with the broader 2025 stock market crash, which started on April 2 amid new tariff policies.  Related:  AI Market Predictions for 2025: Hits, Misses, and Ongoing Trends  as of October 2025 With the Federal Reserve maintaining its rate-cutting trajectory into October 2025 amid heightened market volatility and sector rotation, opportunities are emerging in small caps, semiconductors/AI, value stocks, and gold miners as hedges. Based on recent analyses from Zacks, Morningstar, Yahoo Finance, and ETF experts, we've compiled a forward-looking list of 10 recommendations expected to capitalize on these trends through the end of October and into Q4. Selections emphasize high-conviction picks with upwar...
Read more

Top 10 ETF Picks for October 2025: Best Funds to Buy Now for Growth, Safety, and Diversification Amid Recent Market Volatility

By -
Image
In light of the recent stock market tumble on October 10, 2025, triggered by renewed threats of massive tariffs on Chinese imports announced by President Trump, investors are facing heightened uncertainty. This event has exacerbated ongoing volatility that began earlier in the year with the broader 2025 stock market crash, which started on April 2 amid new tariff policies.  Major U.S. indices sank, with technology stocks hit hardest, amplifying concerns about a potential deeper crash. Jamie Dimon, CEO of JPMorgan Chase, has warned of a significantly higher risk of a U.S. stock market crash than many anticipate, estimating a 30% chance within the next two years. Despite this, opportunities remain in resilient sectors. Gold and bitcoin have surged to record highs as hedges against inflation, rising U.S. debt, and a weakening dollar, making safe-haven and diversified ETFs particularly attractive.  Related:  AI Market Predictions for 2025: Hits, Mi...
Read more

Best Gold and Silver ETFs of 2025: Should You Buy Today? (October 2025 Edition)

By -
Image
As we enter Q4 2025, gold prices have rallied way above $4,000 per ounce, with analysts forecasting potential climbs above $4,100 by year-end amid ongoing geopolitical tensions, central bank buying, and economic uncertainty. Silver, often called "gold's little brother," has rallied above $50 per ounce, driven by industrial demand in solar and electronics, with projections for prices to reach $$55 per ounce by the end of October and potentially higher into November. Gold and silver ETFs have shown strong performance in 2025, surpassing the S&P 500 amid inflation concerns, geopolitical tensions, and central bank buying.  This article updates the best-performing gold and silver ETFs based on recent data, including 1-year returns, assets under management (AUM), expense ratios, and key notes, evaluating their pros, cons, and attractiveness in the current market.The best gold and silver ETFs of 2025 are noted for exceptional performance, low expense ratios, and reliable tra...
Read more

Top 10 Food Companies by Revenue (2025)

By -
Image
Based on the most recent 2025 revenue data, here are the top 10 food companies ranked by revenue: Top 10 Food Companies by Revenue (2025) 1. Nestlé (Switzerland) Revenue:  $101.54 billion Key Brands: Nescafe, KitKat, Maggi, Purina, Waters Notes:  World's largest food company, with a diverse portfolio including bottled water, coffee, frozen foods, and nutrition products. Nestlé Health Science (NHSc), a subsidiary of Nestlé, owns a variety of supplement brands. Some of the most notable ones include: Garden of Life, Vital Proteins, Pure Encapsulations, Wobenzym, Douglas Laboratories, Persona Nutrition, Genestra, Orthica, Minami, AOV, Klean Athlete, Nature's Bounty, Solgar, Osteo Bi-Flex, and Sundown. 2. Ahold Delhaize  (Netherlands) Revenue:  $96.22 billion Notes: Major global food retailer and distributor. 3. PepsiCo (USA) Revenue: $91.52 billion Key Brands: Pepsi, Lay's, Gatorade, Tropi...
Read more

Top XRP ETFs to Watch in 2025: Dominating Holdings, Low Fees, and Performance Insights

By -
Image
As the cryptocurrency market matures in 2025, XRP ETFs have emerged as essential instruments for investors seeking regulated and accessible exposure to this dynamic digital asset. With a growing variety of futures-based and physically backed spot ETFs now available across major markets like the U.S., Canada, and Europe, understanding the nuances of these products—including their fee structures, holdings, and performance—is crucial for making informed investment decisions. This article highlights the top XRP ETFs to watch in 2025, providing deep insights into their dominating holdings, low fees, and recent market impact, all organized in a clear list format for easy navigation. Whether you are a long-term investor or an active trader, this guide will help you identify opportunities and risks in the evolving XRP ETF landscape. Update:  Top Bitcoin, Ethereum, and XRP ETFs to Watch in October 2025 : Updated Performance, AUM, and Investment Insights 1. Leading XRP ETFs in 2025 ProSha...
Read more

AI Demand Drives SSD & Memory Shortages: Prices Set to Rise for a Decade (2025)

By -
Image
Nearly every analyst firm and memory maker is now warning of looming NAND and DRAM shortages that will send SSD and memory prices skyrocketing over the coming months and years, with some even predicting a shortage that will last a decade. The shortages are becoming impossible to ignore, and warnings from the industry are growing dire, as the voracious appetite of AI data centers begins to consume the lion's share of the world's memory and flash production capacity. For the better part of two years, storage upgrades have been a rare bright spot for PC builders. SSD prices cratered to all-time lows in 2023 , with high-performance NVMe drives selling for little more than the cost of a modest mechanical hard disk. DRAM followed a similar trajectory, dropping to price points not seen in nearly a decade. In 2024, the pendulum swung firmly in the other direction, with prices for both NAND flash and DRAM starting to climb. The shift has its roots in the cyclical na...
Read more

Top 10 Healthcare Companies by Revenue in 2025

By -
Image
Here are the top 10 healthcare companies by revenue as of 2024-2025, primarily based on trailing twelve-month (TTM) and fiscal year 2024 revenue data from multiple sources: 1. UnitedHealth Group Inc. (UNH) Revenue (Annual): Approximately $400 billion (2024) Recent YTD Performance: ~ -29%. Description: A leading health insurance company providing data analytics, consulting, and pharmacy care services. Market Capitalisation: ~$323 billion (as of October 2025) Market: NYSE, USA ( 1 ,  2 ,  4 ) 2. CVS Health Corp. (CVS) Recent YTD Performance: ~+80%. ( TradingView ) Recent Market Capitalisation: ~103 B. ( TradingView ) Revenue: Around $361 billion to $373 billion Description: A major pharmacy benefits manager and health services provider. Valuation Assessment: Deeply undervalued. DCF intrinsic $151 (49% under at $77), P/S 0.2x far below peers; 2025 EPS +13% and restructuring signal rebound potential. Market: NYSE, USA ( 1 ,  2 ,  4 ) Final Recommendation: Buy Confidence ...
Read more